Medical Weight Loss Injections in Liverpool: What the Evidence Shows

Trial results that shaped the NICE recommendation

The case for both injectable treatments rests on some of the most closely watched clinical trials in recent memory. In SURMOUNT-1, adults without diabetes who used tirzepatide at the highest dose lost around 20 to 21% of their body weight on average over 72 weeks, a result that NICE described as clinically meaningful when it published its appraisal of tirzepatide (TA1026) in December 2024. If you want to read the underlying data yourself, the SURMOUNT-1 paper in the New England Journal of Medicine sets it out in full.

Semaglutide's STEP 1 trial, run over 68 weeks, produced an average weight reduction of around 15% at the 2.4mg dose. Both figures are population averages from controlled research settings, individual results vary, and no responsible prescriber will promise you a specific outcome. What the trials do confirm is that the biological mechanism is real: these medicines reduce appetite, slow gastric emptying, and change the way hunger hormones signal to the brain.

For Liverpool patients weighing up their options, understanding what medical weight loss injections actually involve clinically is worth doing before booking anything. The results in the trials came alongside structured lifestyle support, which is always part of licensed use.

Who qualifies, and what the NHS pathway looks like in Merseyside

The licensed eligibility criteria for private treatment are straightforward: adults with a BMI of 30 or above, or 27 and above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI is a starting point, not a guarantee, the prescriber looks at the full clinical picture, including any medicines you already take.

The NHS route is more restricted. NICE TA1026 sets out phased criteria; from June 2025, tirzepatide became available in primary care for adults with a BMI of 40 or above and four or more qualifying conditions. A second cohort (BMI 35 to 39.9 with four or more conditions) became eligible from June 2026. GP practices in Liverpool can prescribe under the new contract, but participation varies by practice. NHS England's guidance on weight management injections explains the wraparound care requirements that come with NHS treatment.

If you don't meet the NHS criteria yet, or simply can't wait, the private route through a regulated pharmacy is the legal alternative. You can read more about weight loss injections in Liverpool and what the private pathway involves in practice.

Safety, side effects and when to get help

The side-effect profile of both injections is well-documented. Nausea, loose stools, constipation, reflux and fatigue are the most common complaints, and they tend to be most noticeable in the first days after starting or after a dose increase. Most people find them manageable and temporary. The titration schedule (beginning at a low starter dose before stepping up) exists precisely to give your digestive system time to adjust.

There are a small number of symptoms that need urgent medical attention. Severe, persistent stomach pain that radiates towards the back, with or without vomiting, may indicate pancreatitis. In January 2026 the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as a known risk with GLP-1 medicines, and the message is simple: do not wait to seek help if you experience those symptoms. Gallbladder problems and signs of significant dehydration are also reasons to contact a healthcare professional promptly.

If you experience any side effects you're unsure about, the Yellow Card scheme at yellowcard.mhra.gov.uk lets you report them directly to the MHRA. Our prescribers are also available for aftercare seven days a week, you can find contact details on the support page.

One thing worth knowing if you're on the oral contraceptive pill and starting tirzepatide: NHS guidance advises adding a non-oral contraceptive method for the first four weeks of treatment and for four weeks after each dose increase, as the pill's absorption may be reduced. This does not apply in the same way to semaglutide, but discuss your full medicines list with the prescriber regardless. Pregnancy, breastfeeding and trying to conceive are all clear contraindications for both treatments.

Getting started safely: what to check before ordering anything

These are prescription-only medicines. The only legal way to obtain them in the UK is through a prescription issued following a clinical assessment. Any seller offering weight loss injections without that step is operating outside the law, and the MHRA has warned repeatedly about counterfeit pens (some containing insulin rather than the stated medicine) circulating through unregulated online sellers and social media. Large seizures of fake pens have been made across the UK; report any suspect sellers via Yellow Card.

When you're choosing a provider, check that their pharmacy is listed on the GPhC register. You can verify ours directly at GPhC registration 9012878. At nume, every consultation is read by a GPhC-registered Independent Prescriber (a real clinician, not automated software) on the same day it is submitted. Order before 12pm on a working day and, once approved, your treatment leaves our pharmacy the same afternoon and arrives with DPD the next working day in plain, unbranded packaging. There are no hidden fees and no subscription.

Before you start, it's also worth reading about how to inject weight loss medication correctly, technique matters for both comfort and effectiveness. If you're considering which weight loss medication injection is the right fit for your circumstances, our treatment page walks through the options in detail. And if the question of how much weight loss injections cost is part of your decision, our treatment page sets that out transparently. It's also sensible to understand how weight loss injections can affect the liver, particularly if you have any existing liver conditions, before starting treatment.